1.16 USD
↘ 0.02 (1.71%)AT CLOSE (AS OF 07:31 PM EDT)
Pliant Therapeutics, Inc. Common Stock
PLRXNASDAQ • USD
Market: CLOSED
Pliant Therapeutics, Inc. Common Stock (PLRX) trades at $1.16 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 14, 2026.
Open?$1.16
High?$1.18
Low?$1.15
Prev. Close?$1.17
Volume?208.9K
Avg. Volume?417.1K
VWAP?$1.17
Rel. Volume?0.50x
Bid / Ask
Bid?$1.00 × 100
Ask?$1.33 × 100
Spread?$0.33
Midpoint?$1.16
Valuation & Ratios
Market Cap?72.4M
Shares Out?61.9M
Float?54.3M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?0.49
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Employees
49
Market Cap
72.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-03
Address
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?33
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.40Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?6.04%Elevated
Short Interest?3.3M
Days to Cover?7.2
Free Float54.3M
Avg Daily Volume456.3K
Settlement Date2026-08-31
Financial Health
Current Ratio?9.90Strong
Quick Ratio?9.90Strong
Cash Ratio?1.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.49CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-62.8%WEAK▾
S&P3
ROA?-48.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-70895000
Enterprise Value?$47.6M
Fundamentals ratios updated end of day